Protagonist Therapeutics, Inc.
NASDAQ:PTGX
53.36 (USD) • At close June 23, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28.321 | 170.638 | 4.675 | 4.167 | 254.953 | 60 | 0 | 0 | 0 | 0 | 0 | 0.859 | 25.722 | 8.617 | 10.286 | 2.265 | 6.189 | 5.65 | 13.114 | 6.217 | 3.647 | 2.719 | 4.141 | -8.189 | 1.56 | 2.353 | 6.117 | 11.674 | 10.781 | 11.282 | 8.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.892 | 0.82 | 0.832 | 0.827 | 0.821 | 0.832 | 0.256 | 0.853 | 0.843 | 0.833 | 0.819 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.774 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 28.321 | 170.034 | 4.675 | 3.275 | 254.133 | 59.168 | -0.827 | -0.821 | -0.832 | -0.256 | -0.853 | 0.016 | 24.889 | 7.798 | 10.286 | 2.265 | 6.189 | 5.65 | 13.114 | 6.217 | 3.647 | 2.719 | 4.141 | -10.963 | 1.56 | 2.353 | 6.117 | 11.674 | 10.781 | 11.282 | 8.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0.996 | 1 | 0.786 | 0.997 | 0.986 | 0 | 0 | 0 | 0 | 0 | 0.019 | 0.968 | 0.905 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.339 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 35.893 | 34.904 | 35.97 | 33.52 | 33.734 | 28.899 | 30.664 | 33.182 | 27.416 | 29.884 | 25.402 | 34.611 | 36.318 | 38.373 | 36.956 | 26.432 | 24.245 | 19.486 | 15.995 | 20.257 | 18.768 | 15.911 | 17.293 | 19.355 | 12.444 | 14.248 | 12.145 | 17.735 | 15.368 | 11.724 | 11.168 | 12.007 | 11.282 | 8.823 | 5.561 | 5.696 | 5.625 | 4.193 | 3.158 | 2.297 | 2.183 |
| General & Administrative Expenses
| 11.738 | 8.954 | 10.158 | 9.44 | 14.91 | 8.052 | 7.662 | 9.172 | 8.605 | 6.632 | 6.901 | 7.691 | 10.515 | 7.26 | 7.256 | 6.715 | 5.965 | 4.994 | 4.891 | 4.177 | 4.576 | 4.107 | 4.015 | 3.863 | 3.764 | 3.517 | 3.361 | 3.178 | 3.642 | 3.071 | 2.593 | 3.124 | 2.991 | 2.574 | 1.577 | 1.395 | 1.415 | 0.808 | 0.863 | 0.786 | 0.506 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.892 | -0.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.738 | 8.954 | 10.158 | 8.548 | 14.09 | 8.052 | 7.662 | 9.172 | 8.605 | 6.632 | 6.901 | 7.691 | 10.515 | 7.26 | 7.256 | 6.715 | 5.965 | 4.994 | 4.891 | 4.177 | 4.576 | 4.107 | 4.015 | 3.863 | 3.764 | 3.517 | 3.361 | 3.178 | 3.642 | 3.071 | 2.593 | 3.124 | 2.991 | 2.574 | 1.577 | 1.395 | 1.415 | 0.808 | 0.863 | 0.786 | 0.506 |
| Other Expenses
| 0 | 0 | 0 | 0.097 | -0.019 | 0.044 | -0.031 | -0.019 | -0.195 | 0.071 | -0.086 | -0.078 | 0.013 | -0.013 | 0 | -0.057 | -0.079 | -0.009 | -0.059 | 0 | 0 | 0.142 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.034 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 47.631 | 43.858 | 46.128 | 42.068 | 47.824 | 36.951 | 38.326 | 42.354 | 36.021 | 36.516 | 32.303 | 42.302 | 46.833 | 45.633 | 44.212 | 33.147 | 30.21 | 24.48 | 20.886 | 24.434 | 23.344 | 20.018 | 21.308 | 23.218 | 16.208 | 17.765 | 15.506 | 20.913 | 19.01 | 14.795 | 13.761 | 15.131 | 14.273 | 11.397 | 7.138 | 7.091 | 7.04 | 5.001 | 4.021 | 3.083 | 2.689 |
| Operating Income
| -19.31 | 126.78 | -41.453 | -38.793 | 206.309 | 23.049 | -38.326 | -42.354 | -36.021 | -36.516 | -32.303 | -41.443 | -21.111 | -37.016 | -33.926 | -30.882 | -24.021 | -18.83 | -7.772 | -18.217 | -19.697 | -17.299 | -17.167 | -31.407 | -14.648 | -15.412 | -9.389 | -9.239 | -8.229 | -3.513 | -4.98 | -15.131 | -14.273 | -11.397 | -7.138 | -7.091 | -7.04 | -5.001 | -4.021 | -3.083 | -2.689 |
| Operating Income Ratio
| -0.682 | 0.743 | -8.867 | -9.31 | 0.809 | 0.384 | 0 | 0 | 0 | 0 | 0 | -48.246 | -0.821 | -4.296 | -3.298 | -13.634 | -3.881 | -3.333 | -0.593 | -2.93 | -5.401 | -6.362 | -4.146 | 3.835 | -9.39 | -6.55 | -1.535 | -0.791 | -0.763 | -0.311 | -0.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 7.655 | 6.884 | 7.823 | 7.501 | 4.357 | 4.286 | 4.221 | 3.894 | 2.296 | 2.322 | 1.071 | 0.406 | 0.181 | 0.109 | 0.122 | 0.04 | 0.023 | -0.056 | 0.009 | -0.075 | -0.207 | 0.654 | 0.656 | 0.604 | 0.728 | 0.748 | 0.654 | 0.576 | 0.568 | 0.461 | 0.155 | 0.152 | 0.172 | 0.149 | 0.054 | -0.007 | -4.707 | -0.492 | 0.572 | -0.136 | -0.008 |
| Income Before Tax
| -11.655 | 133.664 | -33.63 | -31.292 | 210.666 | 27.335 | -34.105 | -38.46 | -33.725 | -34.194 | -31.232 | -41.037 | -20.93 | -36.907 | -33.804 | -30.842 | -23.998 | -18.886 | -7.763 | -18.292 | -19.904 | -16.645 | -16.511 | -30.803 | -13.92 | -14.664 | -8.735 | -8.663 | -7.661 | -3.052 | -4.825 | -14.979 | -14.101 | -11.248 | -7.084 | -7.098 | -11.747 | -5.493 | -3.449 | -3.219 | -2.697 |
| Income Before Tax Ratio
| -0.412 | 0.783 | -7.194 | -7.509 | 0.826 | 0.456 | 0 | 0 | 0 | 0 | 0 | -47.773 | -0.814 | -4.283 | -3.286 | -13.617 | -3.878 | -3.343 | -0.592 | -2.942 | -5.458 | -6.122 | -3.987 | 3.762 | -8.923 | -6.232 | -1.428 | -0.742 | -0.711 | -0.271 | -0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 1.99 | -0.42 | -0.676 | 3.326 | -4.242 | -0.827 | -3.913 | -2.296 | -2.909 | -1.071 | -0.406 | -0.181 | -0.832 | 0.122 | -0.057 | -0.079 | -1.305 | -0.04 | 1.129 | 0.176 | 0.856 | -0.102 | -1.629 | 0.183 | -0.799 | 0 | 0 | 0 | -0.117 | -0.108 | 0 | 0 | -0.075 | 0 | -0.027 | 4.707 | 0.492 | -0.572 | 0.136 | 0.008 |
| Net Income
| -11.655 | 131.674 | -33.21 | -30.616 | 207.34 | 27.335 | -34.105 | -38.46 | -31.429 | -31.285 | -30.161 | -40.631 | -20.749 | -36.907 | -33.804 | -30.842 | -23.998 | -18.886 | -7.763 | -19.421 | -20.08 | -17.501 | -16.409 | -29.174 | -14.103 | -13.865 | -8.735 | -8.663 | -7.661 | -3.052 | -4.825 | -14.979 | -14.101 | -11.248 | -7.084 | -7.098 | -11.747 | -5.493 | -3.449 | -3.219 | -2.697 |
| Net Income Ratio
| -0.412 | 0.772 | -7.104 | -7.347 | 0.813 | 0.456 | 0 | 0 | 0 | 0 | 0 | -47.3 | -0.807 | -4.283 | -3.286 | -13.617 | -3.878 | -3.343 | -0.592 | -3.124 | -5.506 | -6.437 | -3.963 | 3.563 | -9.04 | -5.892 | -1.428 | -0.742 | -0.711 | -0.271 | -0.549 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.19 | 2.11 | -0.54 | -0.5 | 3.41 | 0.45 | -0.58 | -0.68 | -0.62 | -0.64 | -0.62 | -0.83 | -0.43 | -0.77 | -0.7 | -0.69 | -0.54 | -0.48 | -0.21 | -0.59 | -0.72 | -0.63 | -0.61 | -1.18 | -0.58 | -0.57 | -0.38 | -0.41 | -0.36 | -0.15 | -0.29 | -0.89 | -0.84 | -0.67 | -0.84 | -0.43 | -2 | -0.93 | -0.59 | -0.55 | -0.46 |
| EPS Diluted
| -0.19 | 1.98 | -0.54 | -0.5 | 3.26 | 0.44 | -0.58 | -0.68 | -0.62 | -0.64 | -0.61 | -0.83 | -0.43 | -0.77 | -0.7 | -0.69 | -0.54 | -0.48 | -0.21 | -0.59 | -0.72 | -0.63 | -0.61 | -1.18 | -0.58 | -0.57 | -0.38 | -0.41 | -0.36 | -0.15 | -0.29 | -0.89 | -0.84 | -0.67 | -0.84 | -0.43 | -2 | -0.93 | -0.59 | -0.55 | -0.46 |
| EBITDA
| -19.071 | 127.316 | -40.806 | -38.793 | 207.129 | 23.881 | -38.326 | -42.354 | -35.189 | -33.938 | -31.45 | -40.194 | -20.097 | -36.988 | -33.222 | -30.254 | -23.397 | -18.571 | -7.418 | -17.538 | -19 | -16.478 | -16.316 | -30.787 | -14.059 | -15.284 | -9.238 | -9.069 | -8.151 | -3.396 | -4.872 | -15.038 | -14.185 | -11.322 | -7.055 | -7.005 | -6.967 | -4.914 | -3.972 | -3.03 | -2.631 |
| EBITDA Ratio
| -0.673 | 0.746 | -8.729 | -9.31 | 0.812 | 0.398 | 0 | 0 | 0 | 0 | 0 | -46.792 | -0.781 | -4.292 | -3.23 | -13.357 | -3.78 | -3.287 | -0.566 | -2.821 | -5.21 | -6.06 | -3.94 | 3.76 | -9.012 | -6.496 | -1.51 | -0.777 | -0.756 | -0.301 | -0.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |